Newsroom

Press Release

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Felicia Williams Joins NeoGenomics Board of Directors

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

NeoGenomics Reports Third Quarter 2024 Results

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia

NeoGenomics Announces New RaDaR Technology and Resolution of RaDaR 1.0 Litigation

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients